Temasek Invests in Yichang Hec Changjiang Pharmaceutical

Posted on 05/10/2017


Singapore’s Temasek Holdings has invested in a Chinese pharmaceutical company that manufactures an anti-flu product, among other drugs. Through a series of subsidiaries, Bartley Investments Pte. Ltd., a sovereign wealth enterprise (SWE) of Temasek Holdings, purchased 15.1 million H shares in Yichang Hec Changjiang Pharmaceutical Company Limited. This transaction was recorded on April 27, 2017. […]